Novel solid self-emulsifying drug delivery system to enhance oral bioavailability of cabazitaxel

Xianxiong Sun,Gaoshuai Lv,Jian Xiong,Jingyi Zhao,Jiansong Zhao,Zhipeng Wang,Yuntao Wang,Tian Yin,Jingxin Gou,Haibing He,Xing Tang,Yu Zhang
DOI: https://doi.org/10.1016/j.ijpharm.2024.123899
IF: 6.51
2024-02-16
International Journal of Pharmaceutics
Abstract:In this study, a novel cabazitaxel solid self-emulsifying drug delivery system (CTX S-SEDDS) was developed by solvent evaporation and liquid–solid compression technology, which overcame the limitations of the traditional SEDDS and improved the oral bioavailability. From the results of solubility, pseudo-ternary phase diagram, and single-factor analysis, Tween 80 (surfactant), Tricaprylin (oil), and Glyceryl monooleate (oil) with the ratio of 30:55:15 showed optimized particle size (140.87 nm), short emulsification and high cabazitaxel (CTX) loading capacity (50 mg·g −1 ). Based on the liquid–solid compression mathematical model, Syloid XDP3050 was determined as carrier material and Syloid 244FP as coating material. The prepared CTX S-SEDDS showed excellent flowability, tabletability, and reconstitution property. In vivo pharmacokinetics in rats demonstrated the absolute bioavailability of CTX S-SEDDS (17.27 %) was significantly enhanced compared with CTX solution (1.69 %), which was close to that of CTX-SEDSS (20.48 %). Lymphatic absorption was verified by in vitro imaging to be an important absorption route for self-emulsifying preparations. These results suggested that CTX S-SEDDS could enhance oral bioavailability of poorly water-soluble drug cabazitaxel while avoiding SEDDS limitations and harnessing the dual advantages of solid and liquid preparations.
pharmacology & pharmacy
What problem does this paper attempt to address?